Search Results
Results found for "Dr. Stuart Maudsley"
- Better GPCR Drug Discovery Decisions Start With Structured Learning
Dr. GPCR University — Reorganized for Clarity and Speed The Dr. In this session, Dr. An upcoming live Ask-Me-Anything (AMA) with Dr. Kenakin takes place February 26 at 12:00 PM EST. Submit your work today ➤ Why Dr. classified publications, priority event tracking, curated career opportunities, and full access to Dr
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
s Corner lecture, Dr. As the GPCR field surges forward—from ligand bias to signaling diversity—the guest editors Dr. Lauren Slosky, Stuart Maudsley and Yamina Berchiche invite your insights for Volume II. ” — Dr. GPCR Podcast Listener Why Dr. FAQ: What You Get with Dr. GPCR Premium 🔹 What’s included?
- Early Stage Biotech Hiring: What Really Holds a Team Together When the Science Starts to Drift
But when the science starts to drift, teams often discover something uncomfortable. When they do not, it starts to fail quietly. The team is talented, but momentum starts leaking. 👉 Early-stage biotech hiring fails at this point, What Survival Traits Look Like in Real Biotech Work 👉 When founders start paying attention, they realize They start asking whether that person can still be effective when the ground shifts under their feet.
- The Imprecision Problem: Why Your GPCR Drug Discovery Program Is Off-Track Before It Even Starts
It means a commitment to continuous improvement — starting with the highest-friction gaps and working
- Inverse Agonists, Lymphatic Fixes & β-arrestin Tricks
Plus, check out the latest Dr. GPCR tools and key moves in the biotech world. Dr. Become a Dr. GPCR Ambassador - Share & refer with Dr. GPCR. Join the Affiliate Program Your Shortcut to Dr. The Dr. Best wishes, The Dr. GPCR Team
- To probe the activation mechanism of the Delta opioid receptor by an agonist ADL5859 started from...
September 2022 To probe the activation mechanism of the Delta opioid receptor by an agonist ADL5859 started
- Exclusive Access: Terry's Corner is LIVE + Your Premium Member Discount!
As a valued Dr. Your Exclusive Premium Member Benefit: As a thank you for your continued support of the Dr. GPCR Ecosystem, we're giving Dr. Explore Terry's Corner Better decisions start with better pharmacology. Warmest Regards, The Dr. GPCR Team & Terry’s Desk
- Beyond the Probe: Scaling Innovation From the Bench to Product Launch
In Episode 168 of the Dr. GPCR Podcast, Dr. And that mindset is precisely what makes their new partnership with Dr. GPCR so powerful. ” — Dr. That’s the mission. ” — Dr. Maria Majellaro Now, as official partners of the Dr. Keyword Cloud: GPCR data platform , fluorescent ligands , assay development , GPCR research community , Dr
- Are You Guessing or Forecasting? Master GPCR Pharmacologic Models Before It’s Too Late
Secure Your Access Now ➤ 🗣️ “Thank you for bringing this (Principles of Pharmacology I) course with Dr I wish Dr. best for the sake of promoting more educational opportunities that are sorely needed in the field” — Dr GPCR University Learner Dr. GPCR Podcast - Surviving Discovery’s Gauntlet Dr. Get ahead, stay relevant, and lead—starting today. The Dr. GPCR Team Read Full Edition ➤
- The Chemistry of Confidence: Aha Moments That Shape Scientific Careers
Dr. Maria Majellaro’s story, shared in Episode 168 of the Dr. ” — Dr. Maria Majellaro Maria didn’t always know she’d end up in a startup. ” — Dr. With the new Dr. . 👉 Explore Celtarys’ tools and partnership with Dr.
- Maria’s Travel Blogs: ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025
. - Dr. Wendy Young’s talk, during session 3 on day 2, was also incredible. . - Dr. Wednesday was a key day for Maria, as she got to participate in a panel discussion alongside Dr. Shoichet, Dr. Luc Van Hijfte and Dr. Wendy Young. Amanda Dombrowski from Abbvie, Dr. Charles Yeung from Merck and Dr.
- Mapping Motion: Intermediate States, Deorphanization & Discovery
GPCR Colleagues & Curiosity-Driven Minds, We’re starting with exciting Dr. sharpen your skills with our new on-demand course, Techniques for Effective Lead Optimization with Dr Dr. Catch up on past Dr. Stay curious, The Dr. GPCR Team
- From Lab Bench to Boardroom: The Unexpected Path of a Medicinal Chemist
For Dr. In this episode of the Dr. ” — Dr. Maria Majellaro Maria’s career didn’t start with a desire to launch a company. Celtarys Research, now partnering with Dr. ____________ Keyword Cloud: GPCR drug discovery , GPCR research community , medicinal chemistry , Dr
- New Podcast, Sweet Structures & $2.2B GPCR Moves
Hello Sweet GPCR Enthusiasts, This week at Dr. GPCR: a new podcast episode with Dr. Ben Clements, a tour of our official Dr. Scroll down for the science, the strategy, and the sweet stuff 🍬 Dr. The official Dr. GPCR Store is live! Best wishes, The Dr. GPCR Team
- New Tools, Smart Signals, and The Kenakin Brief
, we’re spotlighting Celtarys Research, our newest partner, featured in a blog and podcast with CSO Dr After 40+ years and 250 publications, Dr. Dr. Explore Terry's Corner From Chemistry Lab to GPCR Partner – New Podcast with Celtarys Dr. Stay curious, The Dr. GPCR Team
- GPCR Pharmacology Insights That Prevent Real Drug Discovery Failures
Dr. Dr. Dr. Dr. Dr.
- Molecular creativity in drug discovery
GPCR Podcast: Leadership, Impact, and GPCR Signaling with Dr. Dr. Yamina’s open letter reflects on how Dr. I wish Dr. No matter where you are in your GPCR journey, Dr.
- Terry’s Corner, Celtarys' Leap, and the $7B GPCR Horizon
The Corner comes will live monthly AMA sessions with Dr. Kenakin. GPCR Updates Learn Pharmacology That Drives Discovery – From Dr. Explore Dr. This blog post breaks down Dr. Stay curious, The Dr. GPCR Team
- GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026
In this Terry’s Corner lesson, Dr. Join before year-end to secure both. 👉 Join Terry's Corner Before Dec 31st, 2025 🎧 Dr. Hudson 🎧 Catch up on Part 2 with Dr. GPCR Year in Review: Carrying Better Experiments Into 2026 As 2025 closes, the Dr. Beyond access, Premium sustains the nonprofit mission behind Dr.
- The Truth About GPCR Product Launches: Years in the Making
Featuring logos from Dr. GPCR and Revvity. In this behind-the-scenes look at the making of Revity’s pHSense, Dr. Dr. Want to hear Dr. Trinquet tell the story in his own words? GPCR Dr. GPCR X Revvity Collaboration ⸻ Want more like this? 👉 Join the Dr.
- How System-Level GPCR Thinking Prevents Discovery Failures
Dr. GPCR Podcast: Chemical Probes for GPCR Imaging with Dr. In this episode, Dr. I will keep Dr. GPCR and the offered resources in my work sphere." Donate : https://www.ecosystem.drgpcr.com/donate Dr.
- Why Mastering Pharmacokinetics Fundamentals Still Defines Discovery Success Today
When PK is misunderstood early, Dr. derail programs Every therapeutic area—CNS, cardiovascular, GI—faces the same core PK constraints Dr Across therapeutic classes, Dr. small molecules, but protein binding, transporters, and tissue architecture play decisive roles Dr Why Terry’s Corner Terry’s Corner delivers weekly pharmacology lectures from Dr.
- Inside Out: Mapping GPCRs from Membrane Codes to Market Moves
This week at Dr. Dr. Led by Dr. Access the Course Hacking GPCRs: A Toolkit for Systems Biology – New Podcast Episode In Episode 167, Dr Tom Sakmar and Dr.
- Assay Volume Control: Your GPCR Drug Discovery Power Lever
GPCR–ligand kinetics; and cryo-EM uncovers a new allosteric site on an orphan GPCR. 🔍 This Week in Dr In this upcoming episode, Dr. In this behind-the-scenes look, Dr. Read the full story➤ Why Dr. I wish Dr.
- Your GPCR Program Decisions Depend on Good Data Interpretation
That’s why this week at Dr. delays key milestones. 🗣️ “Thank you for bringing this (Principles of Pharmacology I) course with Dr I wish Dr. Ingo Hartung : State-of-the-art design of small molecule drugs, including PROTACs Dr. Get The Full Story ➤ Why Dr. GPCR Premium Membership Gives You an Edge Dr.
- How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program
This week Dr. In this week's Dr. Dr. “The best pharmacology teacher (Dr. Dr.
- Signals in Motion: Pain, Metabolism & Terry’s Corner
Hello GPCR Innovators , We’re preparing to launch Terry’s Corner, a new knowledge hub shaped by Dr. Plus, Celtarys explores ligand selection for better assays, and co-founder Dr. pain relief in preclinical models Dr.GPCR Updates Terry’s Corner – Build Better GPCR Screens with Dr Screening Strategy Leadership in Ligand Design – The Celtarys Origin Story In this founder interview , Dr Best, The Dr. GPCR Team
- How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights
Week’s GPCR Intelligence: From Set-Point Pharmacology to No-Wash Internalization Assays This week’s Dr Unlock On-Demand Yearly Access Now — Premium Members Get Over 50% Discount at Checkout ➤ Revvity x Dr GPCR: A Mission-Aligned Partnership That Advances the Field At Dr. As Dr. Eric Trinquet shares in a special Dr. I will keep Dr.
- How Schild Analysis Protects Your Conclusions in GPCR Research
In this week’s lesson, Dr. Access this week’s key insight ➤ Dr. Dr. 👉 Access this week’s full Premium Edition here ➤ What Members Say “Dr. See you in the Ecosystem, Dr. GPCR Team
